{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:25:12Z","timestamp":1774351512245,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,24]]},"DOI":"10.7759\/cureus.105747","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:29:46Z","timestamp":1774344586000},"source":"Crossref","is-referenced-by-count":0,"title":["Can Scorpion Venom Peptides Be Safely Used in Cardiovascular Therapy: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Sandeep V","family":"Binorkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjeet","family":"Sawant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashtrapal N","family":"Ukey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravindra","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s10989-024-10671-1","article-title":"Scorpion venom peptides as therapeutic agents in cardiovascular diseases: a systematic review","author":"Santos F","unstructured":"Santos F, Silva M, De Matos I. Scorpion venom peptides as therapeutic agents in cardiovascular diseases: a systematic review. Inter Jr Pep Res Ther. 10.1007\/s10989-024-10671-1","journal-title":"Inter Jr Pep Res Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/toxins15040238","article-title":"Scorpion peptides and ion channels: an insightful review of mechanisms and drug development","volume":"15","author":"Mendes LC","year":"2023","unstructured":"Mendes LC, Viana GM, Nencioni AL, et al.. Scorpion peptides and ion channels: an insightful review of mechanisms and drug development. Toxins (Basel). 2023, 15:10.3390\/toxins15040238","journal-title":"Toxins (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmcr.2022.100068","article-title":"Structure, function and mechanistic aspects of scorpion venom peptides - A boon for the development of novel therapeutics","volume":"6","author":"Suhas R","year":"2022","unstructured":"Suhas R. Structure, function and mechanistic aspects of scorpion venom peptides - A boon for the development of novel therapeutics. Eur Jr Med Chem Rep. 2022, 6:10.1016\/j.ejmcr.2022.100068","journal-title":"Eur Jr Med Chem Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2174\/0929866525666180614114307","article-title":"Scorpion venom peptides as a potential source for human drug candidates","volume":"25","author":"Uzair B","year":"2018","unstructured":"Uzair B, Bint-E-Irshad S, Khan BA, et al.. Scorpion venom peptides as a potential source for human drug candidates. Protein Pept Lett. 2018, 25:702-8. 10.2174\/0929866525666180614114307","journal-title":"Protein Pept Lett"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5812\/jjnpp-134049","article-title":"Current status of peptide medications and the position of active therapeutic peptides with scorpion venom origin","author":"Baradaran M","year":"2023","unstructured":"Baradaran M. Current status of peptide medications and the position of active therapeutic peptides with scorpion venom origin. Jund Jr Nat Pharma Prod. 2023, 10.5812\/jjnpp-134049","journal-title":"Jund Jr Nat Pharma Prod"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2023.12.012","article-title":"The complex repertoire of Tityus spp. venoms: Advances on their composition and pharmacological potential of their toxins","author":"Wiezel GA","year":"2024","unstructured":"Wiezel GA, Oliveira IS, Reis MB, et al.. The complex repertoire of Tityus spp. venoms: Advances on their composition and pharmacological potential of their toxins. Biochimie. Elsevier, 2024. 220:144-66. 10.1016\/j.biochi.2023.12.012"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/toxins17030114","article-title":"Short peptides from Asian scorpions: bioactive molecules with promising therapeutic potential","volume":"17","author":"Xin K","year":"2025","unstructured":"Xin K, Sun R, Xiao W, et al.. Short peptides from Asian scorpions: bioactive molecules with promising therapeutic potential. Toxins (Basel). 2025, 17:10.3390\/toxins17030114","journal-title":"Toxins (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-020-09602-5","article-title":"Bradykinin-potentiating activity of a gamma-irradiated bioactive fraction isolated from scorpion (Leiurus quinquestriatus) venom in rats with doxorubicin-induced acute cardiotoxicity: favorable modulation of oxidative stress and inflammatory, fibrogenic and apoptotic pathways","volume":"21","author":"Ahmed LA","year":"2021","unstructured":"Ahmed LA, Abdou FY, El Fiky AA, et al.. Bradykinin-potentiating activity of a gamma-irradiated bioactive fraction isolated from scorpion (Leiurus quinquestriatus) venom in rats with doxorubicin-induced acute cardiotoxicity: favorable modulation of oxidative stress and inflammatory, fibrogenic and apoptotic pathways. Cardiovasc Toxicol. 2021, 21:127-41. 10.1007\/s12012-020-09602-5","journal-title":"Cardiovasc Toxicol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.13202","article-title":"Bradykinin-potentiating factor isolated from Leiurus quinquestriatus scorpion venom alleviates cardiomyopathy in irradiated rats via remodelling of the RAAS pathway","volume":"47","author":"Hasan HF","year":"2020","unstructured":"Hasan HF, Radwan RR, Galal SM. Bradykinin-potentiating factor isolated from Leiurus quinquestriatus scorpion venom alleviates cardiomyopathy in irradiated rats via remodelling of the RAAS pathway. Clin Exp Pharmacol Physiol. 2020, 47:263-73. 10.1111\/1440-1681.13202","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2008.04.104","article-title":"Tityus serrulatus Hypotensins: a new family of peptides from scorpion venom","volume":"371","author":"Verano-Braga T","year":"2008","unstructured":"Verano-Braga T, Rocha-Resende C, Silva DM, et al.. Tityus serrulatus Hypotensins: a new family of peptides from scorpion venom. Biochem Biophys Res Commun. 2008, 371:515-20. 10.1016\/j.bbrc.2008.04.104","journal-title":"Biochem Biophys Res Commun"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2010.04.006","article-title":"Structure-function studies of Tityus serrulatus Hypotensin-I (TsHpt-I): A new agonist of B(2) kinin receptor","volume":"56","author":"Verano-Braga T","year":"2010","unstructured":"Verano-Braga T, Figueiredo-Rezende F, Melo MN, et al.. Structure-function studies of Tityus serrulatus Hypotensin-I (TsHpt-I): A new agonist of B(2) kinin receptor. Toxicon. 2010, 56:1162-71. 10.1016\/j.toxicon.2010.04.006","journal-title":"Toxicon"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/0196-9781(95)02036-5","article-title":"A bradykinin-potentiating peptide (peptide K12) isolated from the venom of Egyptian scorpion Buthus occitanus","volume":"16","author":"Meki A","year":"1995","unstructured":"Meki A, Nassar A, Rochat H. A bradykinin-potentiating peptide (peptide K12) isolated from the venom of Egyptian scorpion Buthus occitanus. Peptides. 1995, 16:1359-1365. 10.1016\/0196-9781(95)02036-5","journal-title":"Peptides"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.0c00290","article-title":"Moving pieces in a cellular puzzle: a cryptic peptide from the scorpion toxin Ts14 activates AKT and ERK signaling and decreases cardiac myocyte contractility via dephosphorylation of phospholamban","volume":"19","author":"Gom\u00e9z-Mendoza DP","year":"2020","unstructured":"Gom\u00e9z-Mendoza DP, Lemos RP, Jesus IC, et al.. Moving pieces in a cellular puzzle: a cryptic peptide from the scorpion toxin Ts14 activates AKT and ERK signaling and decreases cardiac myocyte contractility via dephosphorylation of phospholamban. J Proteome Res. 2020, 19:3467-77. 10.1021\/acs.jproteome.0c00290","journal-title":"J Proteome Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13060407","article-title":"Colombian scorpion Centruroides margaritatus: purification and characterization of a gamma potassium toxin with full-block activity on the hERG1 channel","volume":"13","author":"Beltr\u00e1n-Vidal J","year":"2021","unstructured":"Beltr\u00e1n-Vidal J, Carcamo-Noriega E, Pastor N, et al.. Colombian scorpion Centruroides margaritatus: purification and characterization of a gamma potassium toxin with full-block activity on the hERG1 channel. Toxins (Basel). 2021, 13:10.3390\/toxins13060407","journal-title":"Toxins (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.792697","article-title":"A mutant of the Buthus martensii Karsch antitumor-analgesic peptide exhibits reduced inhibition to hNa(v)1.4 and hNa(v)1.5 channels while retaining analgesic activity","volume":"292","author":"Xu Y","year":"2017","unstructured":"Xu Y, Meng X, Hou X, et al.. A mutant of the Buthus martensii Karsch antitumor-analgesic peptide exhibits reduced inhibition to hNa(v)1.4 and hNa(v)1.5 channels while retaining analgesic activity. J Biol Chem. 2017, 292:18270-80. 10.1074\/jbc.M117.792697","journal-title":"J Biol Chem"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197167","article-title":"Functional impact of BeKm-1, a high-affinity hERG blocker, on cardiomyocytes derived from human-induced pluripotent stem cells","volume":"21","author":"De Waard S","year":"2020","unstructured":"De Waard S, Montnach J, Ribeiro B, et al.. Functional impact of BeKm-1, a high-affinity hERG blocker, on cardiomyocytes derived from human-induced pluripotent stem cells. Int J Mol Sci. 2020, 21:10.3390\/ijms21197167","journal-title":"Int J Mol Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-017-3029-6","article-title":"Effect of a bradykinin-potentiating factor isolated from scorpion venom (Leiurus quinquestriatus) on some blood indices and lipid profile in irradiated rats","volume":"434","author":"Salman MM","year":"2017","unstructured":"Salman MM, Kotb AM, Haridy MA, et al.. Effect of a bradykinin-potentiating factor isolated from scorpion venom (Leiurus quinquestriatus) on some blood indices and lipid profile in irradiated rats. Mol Cell Biochem. 2017, 434:1-6. 10.1007\/s11010-017-3029-6","journal-title":"Mol Cell Biochem"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/toxins15010033","article-title":"Exploring the pivotal components influencing the side effects induced by an analgesic-antitumor peptide from scorpion venom on human voltage-gated sodium channels 1.4 and 1.5 through computational simulation","volume":"15","author":"Zhao F","year":"2022","unstructured":"Zhao F, Fang L, Wang Q, Ye Q, He Y, Xu W, Song Y. Exploring the pivotal components influencing the side effects induced by an analgesic-antitumor peptide from scorpion venom on human voltage-gated sodium channels 1.4 and 1.5 through computational simulation. Toxins (Basel). 2022, 15:10.3390\/toxins15010033","journal-title":"Toxins (Basel)"},{"key":"ref19","article-title":"From traditional medicine to targeted therapy: Structure-activity relationship-guided optimization of scorpion toxin DKK2 for pain-associated sodium channel blockade","volume":"352","author":"Liu Y","year":"2025","unstructured":"Liu Y, Liu Y, Liu Y, et al.. From traditional medicine to targeted therapy: Structure-activity relationship-guided optimization of scorpion toxin DKK2 for pain-associated sodium channel blockade. J Ethnopharmacol. 2025, 352:120238.","journal-title":"J Ethnopharmacol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1661384","article-title":"Toxins are an excellent source of therapeutic agents against cardiovascular diseases","volume":"44","author":"Koh CY","year":"2018","unstructured":"Koh CY, Modahl CM, Kulkarni N, Kini RM. Toxins are an excellent source of therapeutic agents against cardiovascular diseases. Semin Thromb Hemost. 2018, 44:691-706. 10.1055\/s-0038-1661384","journal-title":"Semin Thromb Hemost"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26082223","article-title":"Snake venom components: tools and cures to target cardiovascular diseases","volume":"26","author":"Frangieh J","year":"2021","unstructured":"Frangieh J, Rima M, Fajloun Z, Henrion D, et al.. Snake venom components: tools and cures to target cardiovascular diseases. Molecules. 2021, 26:10.3390\/molecules26082223","journal-title":"Molecules"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.32607\/actanaturae.11375","article-title":"Cardiovascular effects of snake toxins: cardiotoxicity and cardioprotection","volume":"13","author":"Averin AS","year":"2021","unstructured":"Averin AS, Utkin YN. Cardiovascular effects of snake toxins: cardiotoxicity and cardioprotection. Acta Naturae. 2021, 13:4-14. 10.32607\/actanaturae.11375","journal-title":"Acta Naturae"},{"key":"ref23","article-title":"Venom natriuretic peptides guide the design of heart failure therapeutics","volume":"155","author":"Sridharan S","year":"2020","unstructured":"Sridharan S, Kini R, Richards A, et al.. Venom natriuretic peptides guide the design of heart failure therapeutics. Phar Res. 2020, 155:104687.","journal-title":"Phar Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24152778","article-title":"Hypotensive snake venom components-a mini-review","volume":"24","author":"P\u00e9terfi O","year":"2019","unstructured":"P\u00e9terfi O, Boda F, Szab\u00f3 Z, et al.. Hypotensive snake venom components-a mini-review. Molecules. 2019, 24:10.3390\/molecules24152778","journal-title":"Molecules"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/biom13101539","article-title":"Snake venom components as therapeutic drugs in ischemic heart disease","volume":"13","author":"Messadi E","year":"2023","unstructured":"Messadi E. Snake venom components as therapeutic drugs in ischemic heart disease. Biomolecules. 2023, 13:10.3390\/biom13101539","journal-title":"Biomolecules"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116015","article-title":"Biomedical applications of synthetic peptides derived from venom of animal origin: A systematic review","volume":"170","author":"D\u00edaz-G\u00f3mez JL","year":"2024","unstructured":"D\u00edaz-G\u00f3mez JL, Mart\u00edn-Estal I, Rivera-Aboytes E, et al.. Biomedical applications of synthetic peptides derived from venom of animal origin: A systematic review. Biomed Pharmacother. 2024, 170:116015. 10.1016\/j.biopha.2023.116015","journal-title":"Biomed Pharmacother"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2174\/0929867323666161028155611","article-title":"Snake venom peptides and low mass proteins: molecular tools and therapeutic agents","volume":"24","author":"Almeida JR","year":"2017","unstructured":"Almeida JR, Resende LM, Watanabe RK, et al.. Snake venom peptides and low mass proteins: molecular tools and therapeutic agents. Curr Med Chem. 2017, 24:3254-82. 10.2174\/0929867323666161028155611","journal-title":"Curr Med Chem"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/toxins4111082","article-title":"Scorpion toxins specific for potassium (K+) channels: a historical overview of peptide bioengineering","volume":"4","author":"Bergeron ZL","year":"2012","unstructured":"Bergeron ZL, Bingham JP. Scorpion toxins specific for potassium (K+) channels: a historical overview of peptide bioengineering. Toxins (Basel). 2012, 4:1082-119. 10.3390\/toxins4111082","journal-title":"Toxins (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/457700-can-scorpion-venom-peptides-be-safely-used-in-cardiovascular-therapy-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:29:47Z","timestamp":1774344587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/457700-can-scorpion-venom-peptides-be-safely-used-in-cardiovascular-therapy-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.105747","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,24]]}}}